Comment to the editorial: Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons, by Vincent Soriano and Javier García-Samaniego.
Puoti
Massimo
M
Department of Infectious Diseases, University of Brescia--AO Spedali Civili, Brescia, Italy. m.puoti@iol.it
Bruno
Raffaele
R
Castelli
Francesco
F
Filice
Gaetano
G
Carosi
Giampiero
G
D019380:Anti-HIV Agents / Q000009:adverse effects; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001706:Biopsy / Q000706:statistics & numerical data*; D005838:Genotype; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000821:virology; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000473:pathology* / Q000821:virology*; D008103:Liver Cirrhosis / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D017410:Practice Guidelines as Topic; D012367:RNA, Viral / Q000032:analysis; D012680:Sensitivity and Specificity
D019380:Anti-HIV Agents; D012367:RNA, Viral